5% STAKE4582.TTSE GROWTHUNITED KINGDOM

Cantor Fitzgerald Europe lowers stake in SymBio Pharmaceuticals to 9.26%

Stake history

0%5%10%15%6.67%Jan 16Jan 16: 6.67% · S100V3DA5.01%Jan 23Jan 23: 5.01% · S100V4J711.33%Feb 10Feb 10: 11.33% · S100V7PO10.22%Feb 17Feb 17: 10.22% · S100V9AO9.11%Feb 28Feb 28: 9.11% · S100VBO57.44%Mar 25Mar 25: 7.44% · S100VG5J13.68%Apr 16Apr 16: 13.68% · S100VMQK9.26%Mar 2Mar 2: 9.26% · S100XO5M
0%5%10%15%6.67%Jan 16Jan 16: 6.67% · S100V3DA5.01%Jan 23Jan 23: 5.01% · S100V4J711.33%Feb 10Feb 10: 11.33% · S100V7PO10.22%Feb 17Feb 17: 10.22% · S100V9AO9.11%Feb 28Feb 28: 9.11% · S100VBO57.44%Mar 25Mar 25: 7.44% · S100VG5J13.68%Apr 16Apr 16: 13.68% · S100VMQK9.26%Mar 2Mar 2: 9.26% · S100XO5M

Summary

Cantor Fitzgerald Europe filed a Change in 5%+ stake (change report) via EDINET on 2026-03-02 13:03 JST concerning SymBio Pharmaceuticals Limited. Reported holding ratio: 9.26%, previous report: 13.68%.

Open the price chart on TradingView.

Source: EDINET S100XO5M ↗ · PDL1.0 · Not investment advice